The acute and long-term effectiveness of amisulpride in patients with schizophrenia: results of a 12-month open-label prospective follow-up study-Reference-Cited by-同舟云学术

The acute and long-term effectiveness of amisulpride in patients with schizophrenia: results of a 12-month open-label prospective follow-up study

Published:2011-12 Issue:8 Volume:26 Page:568-577
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol Clin Exp

Author:

Ahn Yong Min¹,Lee Kyu Young²,Kim Chul-Eung³,Kang Dae-Yeob⁴,Seok Jeong-Ho⁵,Shin Young Min⁶,Chung In-Won⁷,Jun Tae-Youn⁸,Chang Jae Seung⁹,Kim Yong Sik¹

Affiliation:

1. Department of Psychiatry and Behavioral Science and Institute of Human Behavioral Medicine; Seoul National University College of Medicine, Seoul National University Hospital; Seoul; Korea

2. Department of Neuropsychiatry; Eulji University School of Medicine, Eulji General Hospital; Seoul; Korea

3. Department of Psychiatry; Inha University College Medicine; Incheon; Korea

4. Department of Psychiatry; Yong-In Mental Hospital; Yong-In; Korea

5. Department of Psychiatry, Hallym Sacred Heart Hospital; Hallym University College of Medicine; Gyeonggi-do; Korea

6. Department of Psychiatry; Seoul Bukbu Geriatric Hospital 48; Seoul; Korea

7. Department of Psychiatry; Dongguk University College of Medicine, Dongguk University International Hospital; Gyeonggi-do; Korea

8. Department of Psychiatry, St. Mary's Hospital; The Catholic University; Seoul; Korea

9. Department of Psychiatry; Seoul National University Bundang Hospital; Gyeonggi-do; Korea

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hup.1246/fullpdf

Reference51 articles.

1. Changes in neurocognitive function in patients with schizophrenia after starting or switching to amisulpride in comparison with the normal controls;Ahn;J Clin Psychopharmacol,2009

2. Treatment of negative symptoms in schizophrenia with amisulpride;Boyer;Br J Psychiatry,1995

3. Deficit and nondeficit forms of schizophrenia: the concept;Carpenter;Am J Psychiatry,1988

4. Differential efficacy of risperidone versus haloperidol in psychopathological subtypes of subchronic schizophrenia;Cavallaro;Hum Psychopharmacol,2001

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of Self-Report Cognitive Function for the Symptomatic Remission in Schizophrenia Treated with Amisulpride: a Multicenter, 8-Week Case-Control Study;Psychiatric Quarterly;2021-01-03

2. Cognitive Effects of Combined Amisulpride and Quetiapine Treatment in Patients With Refractory Schizophrenia: A Naturalistic, Prospective Study;American Journal of Therapeutics;2020-07

3. Prolactin Level in Patients with First Episode Schizophrenia Treated for One Year with Atypical Antipsychotics;Acta Endocrinologica (Bucharest);2018

4. The effectiveness and safety of amisulpride in Chinese patients with schizophrenia: An 8‐week, prospective, open‐label, multicenter, single‐arm study;Asia-Pacific Psychiatry;2016-03-28

5. Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment;European Neuropsychopharmacology;2014-05